Estimating the impact of drug addiction causes heart damage

References

• Achudhan, D., et al., 2022. Antcin K inhibits VCAM-1-dependent monocyte adhesion in human rheumatoid arthritis synovial fibroblasts. Food & Nutrition Research, 66, 1–13.
   Google Scholar
• Adamopoulos, S., et al., 2001. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. European Heart Journal, 22 (9), 791–797.
   PubMed Web of Science ®Google Scholar
• Administration, T. F. a D., 2018. Drug abuse cases and inspection statistics.
   Google Scholar
• Aguirre, G.A., et al., 2018. Insulin-like growth factor 1 in the cardiovascular system. Reviews of Physiology, Biochemistry and Pharmacology, 175, 1–45.
   PubMed Web of Science ®Google Scholar
• Akanji, A.O., and Smith, R.J., 2012. The insulin-like growth factor system, metabolic syndrome, and cardiovascular disease risk. Metabolic Syndrome and Related Disorders, 10 (1), 3–13.
   PubMed Web of Science ®Google Scholar
• Chang, M.H., et al., 2007. Down regulation of IGF-I and IGF-IR gene expression in right atria tissue of ventricular septal defect infants with right atria hypoxemia. Clinica Chimica Acta., 379 (1-2), 81–86.
   PubMed Web of Science ®Google Scholar
• Chang, W.S., et al., 2021. Resveratrol inhibited the metastatic behaviors of cisplatin‐resistant human oral cancer cells via phosphorylation of ERK/p‐38 and suppression of MMP‐2/9. Journal of Food Biochemistry, 45 (6), e13666.
   Web of Science ®Google Scholar
• Chen, S.L., et al., 2012. Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment. Journal of Neuroimmune Pharmacology, 7 (4), 1025–1033.
   PubMed Web of Science ®Google Scholar
• Chitnis, M.M., et al., 2008. The type 1 insulin-like growth factor receptor pathway. Clinical Cancer Research, 14 (20), 6364–6370.
   PubMed Web of Science ®Google Scholar
• Cleutjens, J.P., et al., 1995. Regulation of collagen degradation in the rat myocardium after infarction. Journal of Molecular and Cellular Cardiology, 27 (6), 1281–1292.
   PubMed Web of Science ®Google Scholar
• Creemers, E.E., et al., 2001. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circulation Research, 89 (3), 201–210.
   PubMed Web of Science ®Google Scholar
• Dollery, C.M., McEwan, J.R., and Henney, A.M., 1995. Matrix metalloproteinases and cardiovascular disease. Circulation Research, 77 (5), 863–868.
   PubMed Web of Science ®Google Scholar
• Ewid, M., et al., 2020. AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction. BMC Research Notes, 13 (1), 178.
   PubMed Web of Science ®Google Scholar
• Fazio, S., et al., 1996. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. New England Journal of Medicine, 334 (13), 809–814.
   PubMed Web of Science ®Google Scholar
• Ferdinand, K.C., 2000. Substance Abuse and Hypertension. Journal of Clinical Hypertension, 2 (1), 37–40.
   Google Scholar
• Frishman, W.H., et al., 2003. Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Disease, 5 (4), 253–271.
   PubMedGoogle Scholar
• Ghuran, A., van Der Wieken, L., and Nolan, J., 2001. Cardiovascular complications of recreational drugs: are an important cause of morbidity and mortality. British Medical Journal Publishing Group, 323 (7311), 464–466.
   Google Scholar
• Herzog, E., et al., 1998. Early activation of metalloproteinases after experimental myocardial infarction occurs in infarct and non-infarct zones. Cardiovascular Pathology., 7 (6), 307–312.
   PubMed Web of Science ®Google Scholar
• Higashi, Y., et al., 2016. Insulin-like growth factor-1 receptor deficiency in macrophages accelerates atherosclerosis and induces an unstable plaque phenotype in apolipoprotein E-deficient mice. Circulation, 133 (23), 2263–2278.
   PubMed Web of Science ®Google Scholar
• Jogie-Brahim, S., Feldman, D., and Oh, Y., 2009. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocrine Reviews, 30 (5), 417–437.
   PubMed Web of Science ®Google Scholar
• Joosten, L.A., et al., 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis and Rheumatism, 40 (2), 249–260.
   PubMedGoogle Scholar
• Junnila, R.K., et al., 2013. The GH/IGF-1 axis in ageing and longevity. Nature Reviews. Endocrinology, 9 (6), 366–376.
   PubMed Web of Science ®Google Scholar
• Koay, K.-P., et al., 2021. Hyperglycemia-induced cardiac damage is alleviated by heat-inactivated Lactobacillus reuteri GMNL-263 via activation of the IGF1R survival pathway. Probiotics and Antimicrobial Proteins, 13 (4), 1044–1053.
   PubMed Web of Science ®Google Scholar
• Kontoleon, P.E., et al., 2003. Hormonal profile in patients with congestive heart failure. International Journal of Cardiology, 87 (2-3), 179–183.
   PubMed Web of Science ®Google Scholar
• Kuo, W.W., et al., 2005. Impaired IGF-I signalling of hypertrophic hearts in the developmental phase of hypertension in genetically hypertensive rats. Cell Biochemistry and Function, 23 (5), 325–331.
   PubMed Web of Science ®Google Scholar
• Liu, S.P., et al., 2020. Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis. Nutrition and Metabolism, 17 (1), 1–9.
   Google Scholar
• Lu, C.Y., and Lai, S.C., 2013. Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-kappaB pathway in human astroglia infected with Toxoplasma gondii. Acta Tropica, 127 (1), 14–20.
   PubMed Web of Science ®Google Scholar
• Mishra, P.K., et al., 2013. Cardiac matrix: a clue for future therapy. Biochimica et Biophysica Acta, 1832 (12), 2271–2276.
   PubMed Web of Science ®Google Scholar
• Nakao-Hayashi, J., et al., 1992. Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. Atherosclerosis, 92 (2–3), 141–149.
   PubMed Web of Science ®Google Scholar
• Pan, J., et al., 2019. Association study of a functional variant of TNF-alpha gene and serum TNF-alpha level with the susceptibility of congenital heart disease in a Chinese population. Postgraduate Medical Journal, 95 (1128), 547–551. 1128.
   PubMed Web of Science ®Google Scholar
• Perkel, D., et al., 2012. The potential effects of IGF-1 and GH on patients with chronic heart failure. Journal of Cardiovascular Pharmacology and Therapeutics, 17 (1), 72–78.
   PubMed Web of Science ®Google Scholar
• Radosinska, J., Barancik, M., and Vrbjar, N., 2017. Heart failure and role of circulating MMP-2 and MMP-9. Panminerva Medica, 59 (3), 241–253.
   PubMed Web of Science ®Google Scholar
• Robertson, S.D., Matthies, H.J.G., and Galli, A., 2009. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Molecular Neurobiology, 39 (2), 73–80.
   PubMed Web of Science ®Google Scholar
• Rohde, L.E., et al., 1999. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation, 99 (23), 3063–3070.
   PubMed Web of Science ®Google Scholar
• Shen, J., et al., 2015. Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease. International Journal of Clinical and Experimental Medicine, 8 (3), 4399–4404.
   PubMed Web of Science ®Google Scholar
• Silva, A.C., et al., 2020. Bearing my heart: the role of extracellular matrix on cardiac development, homeostasis, and injury response. Frontiers in Cell and Developmental Biology, 8, 621644.
   PubMed Web of Science ®Google Scholar
• Spinale, F.G., 2002. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circulation Research, 90 (5), 520–530.
   PubMed Web of Science ®Google Scholar
• Torre-Amione, G., et al., 1996. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation, 93 (4), 704–711.
   PubMed Web of Science ®Google Scholar
• Wang, K.C., et al., 2012. Early origins of heart disease: low birth weight and the role of the insulin-like growth factor system in cardiac hypertrophy. Clinical and Experimental Pharmacology & Physiology, 39 (11), 958–964.
   PubMed Web of Science ®Google Scholar
• Wang, D., et al., 2016. Elevated serum ghrelin, tumor necrosis factor-alpha and interleukin-6 in congenital heart disease. Pediatrics International, 58 (4), 259–264.
   PubMed Web of Science ®Google Scholar
• Zhang, S., et al., 2017. Elevated serum levels of ghrelin and TNF-alpha in patients with cyanotic and acyanotic congenital heart disease. World Journal of Pediatrics, 13 (2), 122–128.
   PubMed Web of Science ®Google Scholar